Company patents

Antares Pharma, Inc.

Antares Pharma, Inc. demonstrates a strong and consistent focus on Drug Delivery Devices, which constitutes 83.3% of its patent portfolio, despite a -33.3% decline in patenting activity so far in 2026. While Pharmaceutical Preparations also represents a significant 45.0% of its portfolio, the company appears to be shifting away from Therapeutic Activity (Pharma), which saw a -100.0% decline in 2025, indicating a strategic de-emphasis on this area.

Patent Trend by Technology Area

Yearly patent publications since 2023

Product themes

Product-level themes inferred from filings since 2023, with category chips showing where each theme appears. Select a theme to filter the patents below.

60 US filings (since 2023) · 3 categories · 2 themes

Patents

Showing 1-10 of 88

Page 1 of 9